BioCentury | Dec 1, 2016
Product R&D

De-stressing about NASH

...and presented this August with a publication in Nature Communications in collaboration with researchers at Isomerase Therapeutics Ltd....
...Burnaby, B.C. ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV), New York, N.Y. Enanta Pharmaceuticals Inc. (NASDAQ:ENTA), Watertown, Mass. Isomerase Therapeutics Ltd....
BioCentury | Aug 25, 2016
Distillery Therapeutics

Therapeutics: Mitochondrial complex 1 (MC-1)

...basal oxygen consumption and spare respiratory capacity compared with vehicle. Next steps in collaboration with Isomerase Therapeutics Ltd....
BioCentury | Apr 28, 2014
Clinical News

Isomerase Therapeutics, NeuroVive preclinical data

...BioCentury, June 17, 2013). NeuroVive acquired NVP018 from Biotica Technology Ltd. (Cambridge, U.K.) in 2013. Isomerase Therapeutics Ltd....
BioCentury | Jun 17, 2013
Company News

Isomerase Therapeutics, NeuroVive deal

...Biotica's former senior management team. NeuroVive said details are not disclosed (see BioCentury, March 18). Isomerase Therapeutics Ltd....
Items per page:
1 - 4 of 4
BioCentury | Dec 1, 2016
Product R&D

De-stressing about NASH

...and presented this August with a publication in Nature Communications in collaboration with researchers at Isomerase Therapeutics Ltd....
...Burnaby, B.C. ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV), New York, N.Y. Enanta Pharmaceuticals Inc. (NASDAQ:ENTA), Watertown, Mass. Isomerase Therapeutics Ltd....
BioCentury | Aug 25, 2016
Distillery Therapeutics

Therapeutics: Mitochondrial complex 1 (MC-1)

...basal oxygen consumption and spare respiratory capacity compared with vehicle. Next steps in collaboration with Isomerase Therapeutics Ltd....
BioCentury | Apr 28, 2014
Clinical News

Isomerase Therapeutics, NeuroVive preclinical data

...BioCentury, June 17, 2013). NeuroVive acquired NVP018 from Biotica Technology Ltd. (Cambridge, U.K.) in 2013. Isomerase Therapeutics Ltd....
BioCentury | Jun 17, 2013
Company News

Isomerase Therapeutics, NeuroVive deal

...Biotica's former senior management team. NeuroVive said details are not disclosed (see BioCentury, March 18). Isomerase Therapeutics Ltd....
Items per page:
1 - 4 of 4